Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Hematopoietic SCT (HSCT) has been a treatment modality for many diseases over the last decade. Both the innate and specific immunity are impaired after HSCT. Loss of specific immunity against ...

Chinese CRO Newsummit Biopharma has received a license to an antibody from MRC Technology, a medical research charity, for development of a hepatitis C med. The antibody was developed in the lab of ...

Hepatitis C is a chronic viral infection that doesn’t always cause symptoms, so it’s possible to be infected with the virus for years without feeling ill. (1) The virus spreads through contact with an ...

Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical study involving the German Center for Infection ...

Chronic hepatitis B virus (HBV) infection poses a severe threat to approximately 300 million people worldwide, leading to liver disease and cancer. Approximately four percent of affected persons are ...

Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...

WARMINSTER, Pa., March 26, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced positive preliminary results ...